AstraZeneca earns FDA nod for at-home autoinjector
US FDA approves AstraZeneca’s at-home autoinjector for administration of an add-on treatment for severe asthma, matching the indication of GSK’s rival product, Nucala.
Archives for October 9, 2019
Novartis gets approval for quarterly dosing wet AMD treatment
Novartis receives approval from the US FDA for its treatment for wet AMD, which could set Beovu apart in a competitive field.